34th week of 2009 patent applcation highlights part 46 |
Patent application number | Title | Published |
20090209603 | Olmesartan medoxomil with reduced levels of impurities - The present invention provides the preparation of olmesartan medoxomil containing less than about 0.1% of one or more of the impurities OLM-Me, OLM-Cl, and OLM-eliminate. | 2009-08-20 |
20090209604 | Topical combination therapy for treating acne - Described are aqueous topical compositions containing a combination of benzoyl peroxide, at least one dicarboxylic acid having 6 to 12 carbon atoms, and at least one vitamin B.sub.3 compound in aqueous vehicles containing at least one 1,2-alkanediol having from 5 to 7 carbon atoms. The compositions are suitable for treatment of acne. Also described are methods for topically delivering a medicament to a human patient, in need of the medicament by topically administering to the patient the compositions of the present invention. | 2009-08-20 |
20090209605 | NEMATICIDAL COMPOSITIONS - The present invention concerns nematicidal compounds, their formulation as nematicidal composition and their use for controlling nematodes, preferably plant parasitic nematodes. | 2009-08-20 |
20090209606 | Cancer Treatments - Methods and compositions for treating cancers characterized by death-resistant cancer cells are described. In general, such methods involve administration of a therapeutically effective amount of a compound that induces mitotic catastrophe in the some, and preferably most or all, of the cancerous cells. Methods for assessing the efficacy of such treatments are also provided. | 2009-08-20 |
20090209607 | INHIBITORS OF AKT ACTIVITY - Invented are novel heterocyclic carboxamide compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis. | 2009-08-20 |
20090209608 | DEUTERIUM-ENRICHED ASENAPINE - The present application describes deuterium-enriched asenapine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2009-08-20 |
20090209609 | Thienopyrroles and pyrrolothiazoles as new therapeutic agents - The present invention is directed to novel compounds of Formula (I) | 2009-08-20 |
20090209610 | Polymorphic form of 6-(4-chlorophenyl)-2,2-dimethyl-7-Phenyl-2,3-Dihydro-1h-Pyrrolizin-5-Ylac- etic Acid - The present invention relates to a new crystalline modification of 6-(4-chlorophenyl)-2,2-dmethyl-7-phenyl-2, S-dihydro-1H-pyrrolizin-S-ylacetic acid which is referred to as polymorph B. It has a peak in the solid state | 2009-08-20 |
20090209611 | Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them - Provided are crystalline forms of fluvastatin sodium and processes for their preparation. | 2009-08-20 |
20090209612 | PROCESS FOR THE PREPARATION OF ATORVASTATIN - The invention relates to processes for the preparation of atorvastatin. Atorvastatin is known by the chemical name [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid. The hemi-calcium salt of atorvastatin is useful as an inhibitor of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase). The invention also relates to pharmaceutical compositions that include the atorvastatin or a pharmaceutically acceptable salt thereof and to use of said compositions for treating hypolipidemia, hypocholesterolemia and atherosclerosis. | 2009-08-20 |
20090209613 | Use of allymercaptocaptopril for treating or preventing obesity and obesity related diseases - Use of allylmercaptocaptopril for treating or preventing obesity and/or an obesity related disease or disorder is disclosed. | 2009-08-20 |
20090209614 | GLUTAMINE-CONTAINING COMPOSITIONS AND A METHOD FOR INCREASING BLOOD FLOW USING SAME - The present invention provides a glutamine-containing composition which functions to increase blood flow. Glutamine is present in the composition in an amount of 25 mg/kg body weight to 150 mg/kg body weight. By administering the composition to a subject in need thereof, the blood flow in the capillary vessels can be efficiently increased, while inhibiting any side effects such as low blood pressure. The present invention also provides food or feed containing the composition for increasing blood flow. | 2009-08-20 |
20090209615 | INHIBITORS OF MATRIX METALLOPROTEINASES TO TREAT NEUROLOGICAL DISORDERS - The invention provides methods to treat neurological disorders, opthalmological disorders, or a combination thereof by administering a compound that inhibits MMPs. A compound that inhibits MMPs is represented by the compound of formula (I) shown herein. | 2009-08-20 |
20090209616 | PREPARATION OF ROMIDEPSIN - The invention provides an improved process for preparing romidepsin. The process involves producing, purifying, or storing romidepsin under conditions that prevent the formation of undesired adducts. Purifying romidepsin at an apparent pH lower than approximately 6.0 (e.g., between an apparent pH of 4.0 and 6.0) has been discovered to prevent the reduction of the disulfide bond of romidepsin and the subsequent formation of dimerized, oligomerized, or polymerized adducts. The invention also provides compositions of monomeric romidepsin free of dimerized, oligomerized, or polymerized adducts. | 2009-08-20 |
20090209617 | DULOXETINE SALTS - The subject of the present invention is the provision of new salts of duloxetine of the Formula (I) with organic acids, process for their preparation and medicinal products containing thereof. The new salts are essentially free from the impurity of the Formula (II) and possess high purity and high stability. The new duloxetine salts are prepared by reacting duloxetine free base dissolved in an organic solvent with an approximately equimolar amount of an organic acid. Particularly advantageous crystalline salts are those formed with fumaric acid, citric acid or (−)-mandelic acid. | 2009-08-20 |
20090209618 | Pyruvate dehydrogenase kinases as therapeutic targets for cancer and ischemic diseases - The invention provides therapeutic and prophylactic compounds and methods for altering the activity of pyruvate dehydrogenase kinase (e.g. PDK1, PDK2, PDK3, PDK4). Such therapies are useful for the treatment of neoplasia. The invention further provides therapeutic and prophylactic compounds and methods of altering pyruvate dehydrogenase activity to treat or prevent cell death related to ischemia. | 2009-08-20 |
20090209619 | Depression of herg k+ channel function in mammallan cells and applications to the control of cancer cells division - The use of an HERG channel inhibitor for controlling the proliferation of cancer cells. Examples of such HERG channel inhibitors include dofetilide, cisapride, E-4031 and a siRNA molecule targeting a sequence involved in the expression of an HERG channel. Other ERG channels are also targets for these inhibitors. | 2009-08-20 |
20090209620 | Direct Reversal Of The Suppressive Function Of CD4+Regulatory T Cells Via Toll-Like Receptor 8 Signaling | 2009-08-20 |
20090209621 | Compositions and methods for decreasing microrna expression for the treatment of neoplasia - The invention generally features compositions and methods that are useful for treating or diagnosing a neoplasia. The invention is based in part on the observation that c-Myc activated expression of a cluster of six miRNAs on human chromosome 13. Accordingly, the invention provides therapeutic compositions and methods for altering the expression of a microRNA of the invention thereby treating a neoplasia, as well as compositions and methods for diagnosing a neoplasia. | 2009-08-20 |
20090209622 | Diagnosis of anxiety disorders - The invention relates to methods for diagnosing a genetic predisposition or susceptibility for anxiety disorders in a human. The methods include detecting particular markers at the human RGS2 locus in a sample obtained from the human. The invention also relates to the improved diagnosis that is based on the analysis of haplotypes for the RGS2 locus. | 2009-08-20 |
20090209623 | Anti-sense nucleic acid derived from organism - Disclosed are: a method for producing an anti-sense nucleic acid which has a wide variation in nucleotide sequences and excellent anti-sense properties at a low cost in a simple manner and in a large scale; and a cosmetic composition or pharmaceutical composition comprising the anti-sense nucleic acid. A method is discovered which can produce a low molecular weight nucleic acid having anti-sense properties from a nucleic acid starting material derived from an organism at a high yield by using a probe nucleic acid having at least a part of the nucleotide sequence of a target gene. An anti-sense nucleic acid produced by using a nucleic acid derived from an organism as a starting material; and a method for producing the anti-sense nucleic acid. | 2009-08-20 |
20090209624 | COMPOSITIONS AND THEIR USES FOR GENE THERAPY OF BONE CONDITIONS - In certain preferred embodiments, the present invention provides compositions and methods for the treatment of bone conditions associated with low bone density. In preferred embodiments, the present invention provides compositions and methods for the treatment of osteoprotegerin-responsive conditions. | 2009-08-20 |
20090209625 | MODULATION OF CHREBP EXPRESSION - Disclosed herein are compounds, compositions, and methods for modulating the expression of ChREBP in a cell, tissue or animal. Also provided are methods of target validation. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and conditions. | 2009-08-20 |
20090209626 | Duplex Oligonucleotides with Enhanced Functionality in Gene Regulation - Disclosed are methods of enhancing functionality of duplex oligonucleotides and compositions made by the methods. The duplex oligonucleotides include siRNAs, miRNA mimics, and piRNA mimics which contain modified nucleotides and mismatches between the two strands of the molecule at specific nucleotide positions. | 2009-08-20 |
20090209627 | RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATED CONDITIONS - RNA interference is provided for inhibition of connexin 43 (Cx43) in intraocular pressure-related conditions, including ocular hypertension and glaucoma such as normal tension glaucoma and open angle glaucoma. | 2009-08-20 |
20090209628 | MULTIPLE RNAi EXPRESSION CASSETTES FOR SIMULTANEOUS DELIVERY OF RNAi AGENTS RELATED TO HETEROZYGOTIC EXPRESSION PATTERNS - The present invention provides compositions and methods suitable for expressing y-x multiple-RNAi agents against an allele or alleles of interest in cells, tissues or organs of interest in vitro and in vivo so as to treat diseases. | 2009-08-20 |
20090209629 | Nucleic Acid Functionalized Nanoparticles for Therapeutic Applications - Materials and methods for regulating gene expression using nanoparticles functionalized with antisense oligonucleotides are provided. | 2009-08-20 |
20090209630 | GENE DELIVERY FORMULATIONS AND METHODS FOR TREATMENT OF ISCHEMIC CONDITIONS - The present inventors have developed a novel approach for efficient delivery of angiogenic factors to the cardiac and peripheral vasculature that avoids problems with toxicity inherent to existing delivery technologies. Vectors carrying coding sequences for angiogenic agents including Del-1 or VEGF, or both, can be formulated with poloxamers or other polymers for delivery into ischemic tissue and delivered to areas of peripheral ischemia in a flow to no-flow pattern and to the heart by retrograde venous perfusion. | 2009-08-20 |
20090209631 | METHOD FOR ENHANCED UPTAKE OF VIRAL VECTORS IN THE MYOCARDIUM - The present invention relates to improved therapies for the treatment of heart disease, particularly the improved delivery of therapeutic agents to heart tissue by direct infusion into the coronary circulation. A preferred embodiment of the invention is a method of treating or preventing a cardiovascular disease by transfecting cardiac cells of a large mammal, the method comprising, identifying a mammal in need of treatment or prevention of heart disease, supplying NO to the coronary circulation prior to, and/or during the infusion of a therapeutic polynucleotide into a blood vessel of the coronary circulation in vivo, where the therapeutic polynucleotide is infused into the blood vessel over a period of at least about three minutes, where the coronary circulation is not isolated or substantially isolated from the systemic circulation of the mammal; and where the therapeutic polynucleotide transfects cardiac cells of the animal resulting in the treatment or prevention of the heart disease. | 2009-08-20 |
20090209632 | Percutaneously Absorptive Ophthalmic Preparation Comprising Olopatadine - The present invention provides a percutaneously absorptive preparation for preventing or treating allergic eye disease, which comprises olopatadine or a salt thereof as an active ingredient. In addition, the present invention provides a method for preventing or treating allergic eye disease, which comprises applying a percutaneously absorptive preparation comprising olopatadine or a salt thereof to the skin surface including the skin surface of an eyelid, thereby casing transfer of a therapeutically effective amount of olopatadine or a salt thereof from the preparation to an anterior ocular segment through the skin of the eyelid rather than a systemic blood flow. The present preparation can exert a pharmacological effect over a prolonged period by a single application, as compared to conventional preparations such as eye drops. | 2009-08-20 |
20090209633 | Treatment of Pain With Resiniferatoxin and Related Analogs - A method of treating inflammatory pain conditions is provided that involves administering an effective amount of a TRPV1 agonist, such as resiniferatoxin, tinyatoxin and related potent agonists and their analogs, to a patient to selectively induce nerve terminal depolarization block and/or nerve terminal death in select TRPV1-containing neurons, to provide the desired pain relief without significant permanent damage to cell bodies of the select TRPV-1 containing neurons. | 2009-08-20 |
20090209634 | USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR DISEASE MODIFICATION / EPILEPTOGENESIS - The present invention is a method for treating, preventing, reversing, arresting or inhibiting the occurrence, development and maturation of seizures or seizure-related disorders. More specifically, the present invention is directed to methods for the use of benzo-fused heterocycle sulfamide derivatives of formula (I) and formula (II) as described herein to therapeutically or prophylactically treat, prevent, reverse, arrest or inhibit epileptogenesis and epilepsy. | 2009-08-20 |
20090209635 | TOPICAL CROMOLYN FORMULATIONS - The present invention provides a topical composition comprising (a) at least one delivery agent compound and (b) a cromoglycic acid compound. Methods of treatment, and methods of preparing the topical composition are also provided. | 2009-08-20 |
20090209636 | Novel use of (-)-epigallocatechin gallate - An apparatus for generating a data stream having a series of segments using data organized in subsequent data frames, a data frame having more important and less important data. It comprises a packetiser for packetising data from a data frame into the series of segments having a first segment and a second segment, where the packetiser is operative to packetise the data of the frame so that a starting point of the more important data coincides with a starting point of the first segment and an information block adder for adding a first information block to the first segment. | 2009-08-20 |
20090209637 | USE OF CHROMEN-4-ONE DERIVATIVES - The invention relates to the use of chromen-4-one derivatives of the formula I | 2009-08-20 |
20090209638 | TREATMENT FOR DEPRESSIVE DISORDERS - A method of treating depression comprising administering a melatonin agonist. | 2009-08-20 |
20090209639 | PROCESS FOR MODIFYING DRUG CRYSTAL FORMATION - A process for modifying the crystal habit of acicular drug substances, crystals obtained by such a process, and particular crystal forms or modifications of mycophenolic acid or mycophenolate sodium are provided, as well as pharmaceutical compositions comprising the crystals, methods of treatment and uses thereof. | 2009-08-20 |
20090209640 | Prevention of and countermeasures against viral infection - The present invention relates to a method for treating viral infection, which includes administering arginine and a high dose of vitamin C. It also relates to an agent for treating viral infection, which includes arginine and coated vitamin C. | 2009-08-20 |
20090209641 | PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION BY INJECTION - A pharmaceutical composition for administration by injection, comprising a mixture of platinum complex of general formula (I), wherein A and A′ independently of one another are an NH | 2009-08-20 |
20090209642 | Hydroxy Acid Complexes for Antiaging and Skin Renovation - This invention relates to certain divalent or polyvalent metals of first transition series of the Periodic Table of Elements and including zinc and Molybdenum, complexed concurrently with an amino acid and a hydroxy acid in a novel spirocyclic bidentate chemical complex form (FIG. | 2009-08-20 |
20090209643 | METHOD FOR MODULATING STEM CELL GROWTH - In one embodiment, provided is a composition comprising a prostaglandin compound for modulating stem cell proliferation and/or differentiation in a mammalian subject. In another embodiment, the instant application is a composition comprising a prostaglandin compound for, which comprises a prostaglandin compound for modulating proliferation and/or differentiation of stem cells of a mammalian subject, in which the stem cells are contacted directly or indirectly with the composition of the invention. | 2009-08-20 |
20090209644 | LIPOTOXICITY RELIEVING AGENT - In view of the situation that a clinically acceptable medical agent which has the action of preventing and relieving the lipotoxicity with no significant side effects is not yet provided, such medical agent is provided. An agent for relieving lipotoxicity which comprises an unsaturated fatty acid containing 18 to 22 carbon atoms and having a degree of unsaturation of 3 to 6 or a derivative thereof as its effective component. | 2009-08-20 |
20090209645 | METHODS FOR TREATING VASOMOTOR SYMPTOMS USING GABA ANALOGS IN A GASTRIC RETENTIVE DOSAGE FORM - Methods for treating vasomotor symptoms associated with menopause are described. | 2009-08-20 |
20090209646 | TRANEXAMIC ACID FORMULATIONS - Disclosed are modified release oral tranexamic acid formulations and methods of treatment therewith. | 2009-08-20 |
20090209647 | NUTRITIONAL METHOD - A method of improving nutrition and/or treating low grade inflammation in an elderly human subject comprises administering to said subject a cysteine source so as to provide metabolically available cysteine in the diet of said subject in a proportion relative to all available amino acids which is greater that the proportion of cysteine relative to all amino acids which corresponds to the requirements of a healthy young human subject. | 2009-08-20 |
20090209648 | Phenylacetic Acid Derivatives - Compounds of formula (I) pharmaceutically acceptable salts thereof, and pharmaceutically acceptable esters thereof; which are useful for the treatment of COX-2 dependent disorders. | 2009-08-20 |
20090209649 | ALPHA-GLUCOSIDASE INHIBITOR, INHIBITOR FOR BLOOD GLUCOSE LEVEL ELEVATION AND FUNCTIONAL FOOD CONTAINING TRICAFFEOYLALDARIC ACID AND METHOD FOR PRODUCING TRICAFFEOYLALDARIC ACID - Components that demonstrate an α-glucosidase inhibitory activity and hyperglycemic inhibitory activity have clearly been provided from among the components included in Yacon. The present inventors found that as a result of screening for a strong anti-oxidant component in a Yacon aerial portion extract, an antioxidant activity was converged in a DIAION HP-20 column chromatography 50% methanol-eluted fraction of hot water extract. Thus, since a previously unidentified high-content component was confirmed, the present inventors conducted purification thereof, and thereby separated TCAA. As a result, this TCAA was found to be the component that demonstrates the α-glucosidase inhibitory activity and hyperglycemic inhibitory activity. | 2009-08-20 |
20090209650 | Materials and Methods for Improving the health of Shrimp - The subject invention provides methods for improving shellfish health. In specific embodiments, the invention provides methods for accelerating and/or augmenting shrimp growth; improving immunity; and enhancing fertility in shellfish. To do so, the present invention provides materials and methods for administering a cysteamine compound to shrimp. | 2009-08-20 |
20090209651 | USE OF 3-(4-HYDROXY-3-METHOXYPHENYL)-1-(4-HYDROXYPHENYL) PROPANE-1-ONE FOR IMPROVED SKIN CONTOURING OR AGAINST CELLULITE - A cosmetic or dermatological preparation which is suitable for application to skin and comprises 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-propane-1-one in a concentration which is effective for at least one of increasing skin moisture content, moisturizing skin, improving the surface structure of the skin, reducing cellulite, increasing the resilience and elasticity of skin, strengthening the connective tissue of skin, and reducing stretch marks on skin. This Abstract is not intended to define the invention disclosed in the specification, nor intended to limit the scope of the invention in any way. | 2009-08-20 |
20090209652 | Vitamin K for Prevention and Treatment of Skin Rash Secondary to Anti-EGFR Therapy - The invention provides methods and compositions for treating and preventing a skin rash secondary to anti-epidermal growth factor receptor (EGFR) therapy, where the method comprises applying a vitamin K analog or a phosphatase inhibitor to the skin. | 2009-08-20 |
20090209653 | AGENT FOR INCREASING TESTOSTERONE LEVEL - Provided is a substance which is a safer and more commonly-consumed food ingredient that increase the testosterone level. The testosterone enhancer of the invention comprises vitamin K as an active ingredient. The vitamin is preferably menaquinone-4 and/or menaquinone-7. This enhancer is useful as pharmaceutical agents, supplements, health foods or functional foods for the prevention, amelioration and/or treatment of a condition or disease induced by the decreased testosterone level. | 2009-08-20 |
20090209654 | Prenylflavonoid Formulations - Methods and formulations for increasing the water solubility and/or bioavailability of prenylfiavonoids are disclosed. The formulations may be employed to treat a disease states, including cancer. | 2009-08-20 |
20090209655 | ISOFLAVONE METABOLITES - There are disclosed compounds of formulae (I) or (II) in which A is selected from the group consisting of (1), (2), (3) and (4); OH, and one of R | 2009-08-20 |
20090209656 | DISINFECTION/SANITATION METHOD WHERE THE MATERIAL IS TREATED WITH A SOLUTION COMPRISING BENZYL ALCOHOL AND C2-3 ALCOHOL - The present invention relates to a method for disinfection or sanitation of different material, especially sensitive material, such as chromatographic media with various sensitive ligands. The invention also relates to a composition for use in such a method. The method for disinfection/sanitation, comprises exposing the material to be treated to a solution comprising 5-10% benzyl alcohol and 10-30% C | 2009-08-20 |
20090209657 | Soap Kit for Women's Intimate Hygiene and Composition of Soap for the Menstrual Period - The present invention refers to a soap kit, preferably liquid, for women's intimate hygiene devised to take into consideration the different phases of the menstrual cycle, keeping the vaginal flora and helping to prevent infection. Besides that, the present invention also refers to a soap composition, preferably liquid, for intimate hygiene, with pH between 3.6 and 4.0 for use during the woman menstrual period. Though the soaps segment in the pharmaceutical market presents a variety of options targeting the woman personal hygiene, these do not take into consideration pH variations seen during the different phases of the menstrual cycle. The objective of the present invention is to provide a kit and a composition of intimate soap for women that can preserve vaginal ecosystem through the different menstrual cycle stages, helping in infection prevention and so reducing chances of irritation processes related to soap not specifically made for this part of the body. | 2009-08-20 |
20090209658 | Embolic compositions - Embolic compositions comprising macromers having a backbone comprising a polymeric backbone comprising units with a 1,2-diol or 1,3-diol structure, such as polyvinyl alcohol, and pendant chains bearing crosslinkable groups and, optionally, other modifiers. When crosslinked, the macromers form hydrogels having many properties advantageous for use as embolic agents to block and fill lumens and spaces. The embolic compositions can be used as liquid embolic agents and crosslinked in situ or as preformed embolic articles, such as microspheres. | 2009-08-20 |
20090209659 | Liquid Thickeners for Aqueous Systems - Liquid thickener for aqueous systems containing, as viscosity suppressing agent, from 5 to 40% wt of ethoxylated mono- and/or di-glycerides of carboxylic acids having from 6 to 18 carbon atoms, from 15 to 40% wt of a polyurethane associative thickener, obtained from the reaction of at least one organic polyisocyanate, at least one water soluble polyether diol and at least one hydrophobic capping agent containing from 10 to 24 carbon atoms, from 20 to 80% wt of water, and which is devoid of organic solvents, volatile organic compounds and other viscosity suppressing agents. | 2009-08-20 |
20090209660 | BIOMATERIAL CONTAINING DEGRADATION STABILIZED POLYMER - The present invention relates to a polymer based material comprising a water binding agent, whereas the water binding agent is present in an amount sufficient to chemically and/or physically absorb and/or adsorb water to prevent degradation of the polymer. It also relates to a polymer based material which comprises a plasticizer or organic solvent as well as a multi-component material or composite including materials encompassing a second polymer and/or an active agent. Furthermore it relates to a method for manufacturing the polymer comprising material and use of the material for the preparation of a pharmaceutical composition to be used for treatment of bone, cartilage and/or periodontal defects. The invention also encompasses a kit using the polymeric material. Further, the present invention encompasses the use of a water binding agent for inhibiting water induced degradation of a polymer comprising material, for inducing blood clot stabilization in a polymer comprising material and for increasing storage stability in a polymer comprising material, wherein the water binding agent is not removed prior to application of the material. | 2009-08-20 |
20090209661 | DELIVERY PARTICLE - The present application relates to agglomerates/particles comprising encapsulated, benefit agents, compositions comprising such agglomerates/particles, and processes for making and using such agglomerates/particles and compositions comprising such agglomerates/particles. Such agglomerates/particles are processed to a form that minimizes or eliminate certain drawbacks associated with incorporating encapsulated benefit agents in consumer products. | 2009-08-20 |
20090209662 | ISOMALTULOSE WITH IMPROVED FLOWABILITY - The invention concerns a crystalline isomaltulose product having improved flow properties as bulk product and no tendency toward long-time compaction, method for production of this product as well as a new use of isomaltulose. | 2009-08-20 |
20090209663 | LONG TERM WEIGHT MAINTENANCE - This invention is in the field of weight maintenance, more in particular in the field of long term weight maintenance of humans. The invention relates to the use of a mixture of a triglyceride oil having a solid fat content at ambient to body temperature and an emulsifier for maintaining weight after weight loss. The invention also relates to the use of a mixture of a triglyceride oil having a solid fat content at ambient to body temperature and an emulsifier for obtaining a thermogenic effect. The invention also relates to the use of a mixture of a triglyceride oil having a solid fat content at ambient to body temperature and an emulsifier for increasing the energy expenditure such as resting energy expenditure. | 2009-08-20 |
20090209664 | Demulsifiers and methods for use in pharmaceutical applications - Demulsifiers containing an anionic surfactant selected from alkylsulfosuccinates, alkylsulfonates, alkylphosphonic acids, and their salts; a nonionic surfactant selected from ethylene oxide/propylene oxide copolymers, ethoxylated fatty acids of polyethylene glycol, terpene alkoxylates, and modified alkanolamides; or a combination of an anionic and a nonionic surfactant, and methods of use thereof in breaking emulsions. | 2009-08-20 |
20090209665 | COLLOIDAL TITANIUM DIOXIDE SOLS - Stable, translucent or transparent titanium dioxide sols comprising amorphous titanium dioxide and an organic peptizing agent are provided that are useful in particulate binding applications. Also provided are methods for preparing the inventive sols. The inventive sols are prepared from titanium dioxide precursors including organotitanium compounds and water-soluble titanium salts that are treated to precipitate amorphous titanium dioxide. The amorphous titanium dioxide is re-dispersed and peptized to form a translucent or transparent mixture. The inventive sols are stable for an extended period of time. | 2009-08-20 |
20090209666 | ENVIRONMENTALLY-FRIENDLY OIL/WATER DEMULSIFIERS - The invention relates to particular orthoester based polymers as well as the use of specific orthoester based polymers as a demulsifier for water/oil emulsions. Products suitable for use according to the invention have the formula (I), wherein R1 is hydrogen or a hydrocarbyl group with 1-4 carbon atoms, R2, R3, and R4 are, independently, a group comprising C | 2009-08-20 |
20090209667 | Recycled Poly(vinyl butyral) - The present invention provides a method of recycling poly(vinyl butyral) resin and incorporating that poly(vinyl butyral) resin into laminated glass and other articles. Poly(vinyl butyral) resin is recovered from discarded laminated glass through a well defined process, as described herein as the present invention, that includes all or most of the steps of granulation of the laminated glass, solvent extraction of plasticizer and impurities, dissolution of poly(vinyl butyral), pre-filtration of insoluble contaminants, color removal via adsorption or bleaching, post-filtration of carbon particles, precipitation of poly(vinyl butyral), and washing, stabilization, and drying of poly(vinyl butyral) resin. | 2009-08-20 |
20090209668 | REINFORCED COMPOSITE MEMBRANE FOR POLYMER ELECTROLYTE FUEL CELL - The present invention relates to a method of manufacturing a proton-conducting reinforced composite membrane, and more particularly, to a reinforced composite membrane which is manufactured by introducing an additive into a sulfonated hydrocarbon-based polymer as a proton-conducting material, and impregnating the additive-introduced polymer into a porous polymer having excellent dimensional stability. | 2009-08-20 |
20090209669 | LATENT CURING AGENT - An aluminum chelating agent-based latent curing agent is provided that can rapidly cure thermosetting epoxy resins at relatively low temperatures. A method for producing the aluminum chelating agent-based latent curing agent is also provided that enables relatively facile control of the curing conditions therefor. The latent curing agent holds an aluminum chelating agent in a porous resin obtained by the interfacial polymerization of a polyfunctional isocyanate compound, and when the latent curing agent is incorporated in a curable epoxy resin composition for differential scanning calorimetric (DSC) measurement, the DSC exothermic peak temperature of the curable epoxy resin composition for DSC measurement that contains the latent curing agent that has been treated by immersion in a nonaqueous polar solvent can be brought to not less than the DSC exothermic peak temperature of the curable epoxy resin composition for DSC measurement that incorporates the latent curing agent that has not been subjected to the immersion treatment. | 2009-08-20 |
20090209670 | POLYOLEFIN RESIN FOAM AND THE PROCESS FOR PRODUCING THE SAME - An object of the invention is to provide a polyolefin resin foam which is excellent in flexibility, cushioning property and processability, especially excellent in cutting processability. The present invention relates to a polyolefin resin foam obtained by foaming a polyolefin resin composition using carbon dioxide in a supercritical state, wherein the polyolefin resin composition contains at least: (1) a thermoplastic elastomer composition obtained by subjecting to a dynamically heat treatment a mixture of (A) a rubber, and (B) (B-1) an α-olefin crystalline thermoplastic resin and/or (B-2) an α-olefin amorphous thermoplastic resin, each having a melt tension of less than 3.0 cN at a temperature of 210° C. and at a take-up speed of 2.0 m/min, in the presence of (C) a crosslinking agent; (2) a polyolefin resin; and (3) a nucleant agent having an average particle diameter of from 0.1 μm to less than 2.0 μm. The polyolefin resin foam has a density, for example, of 0.2 g/cm | 2009-08-20 |
20090209671 | METHOD FOR THE PRODUCTION OF RIGID POLYURETHANE FOAM - The invention relates to a process for producing rigid polyurethane foams by reacting
| 2009-08-20 |
20090209672 | Copolymer rubber, rubber composition and rubber molding - The present invention provides a copolymer rubber which contains only small amounts of impurities and is excellent in kneading processability, extrusion processability and retention of shape and a rubber composition containing the copolymer rubber, and further provides a rubber molded product which is obtained from the rubber composition, is excellent in surface appearance, strength properties, heat aging resistance and weathering resistance and has a low compression set. The copolymer rubber of the present invention comprises structural units derived from [A]ethylene, [B] an α-olefin of 3 to 20 carbon atoms, [C] a non-conjugated polyene having one double bond between adjacent carbon atoms in one molecule, said double bond being capable of polymerization by a metallocene catalyst, and [D] a non-conjugated polyene having two of the above double bonds in one molecule, and the copolymer rubber satisfies specific requirements (1) to (5). | 2009-08-20 |
20090209673 | Glazing - A laser can be used to modify a glazing | 2009-08-20 |
20090209674 | RESIN COMPOSITION FOR STEREOLITHOGRAPHY - Provided is a resin composition for stereolithography that absorbs little water and moisture over time in uncured state, maintains a low moisture absorption rate even under high humidity, and has high curing sensitivity, from which a stereolithography product excellent in the properties, such as dimensional accuracy, mechanical properties, and dimensional stability can be smoothly produced for reduced light irradiation time. | 2009-08-20 |
20090209675 | Lanthanum Containing Novel Polyacrylate for Optical Lenses - A process for the preparation of lanthanum containing polyacrylates for optical applications. The process consists in dispersing lanthanum oxide in acrylic acid to form a monomer mixture. An aromatic carboxylic acid is added to the monomer mixture and then a cross linking agent is added thereto. Such a monomer mixture is subjected to the step of polymerization by gamma radiation. | 2009-08-20 |
20090209676 | CROSSLINKED POLYMERS WITH AMINE BINDING GROUPS - Crosslinked polymeric materials are described that contain pendant amine capture groups. The amine capture groups include N-sulfonylaminocarbonyl groups that can react with amine-containing materials by a nucleophilic displacement reaction. Reaction mixtures used to prepare the crosslinked polymeric materials, articles containing the crosslinked polymeric materials, methods of making articles, and methods of immobilizing an amine-containing material are also described. | 2009-08-20 |
20090209677 | Ultraviolet-Curable Resin Composition Containing a Polyfunctional Oxetanyl Group - An ultraviolet curable resin composition, which comprises a cationic photopolymerization initiator (B) and a urethane prepolymer (A) having a structure represented by the general formula ( | 2009-08-20 |
20090209678 | CRAYON - The invention provides a crayon having excellent feel when writing while having high gel hardness. The crayon comprises a colorant, a gelling agent, an organic solvent and a resin component, wherein the gelling agent is at least one selected from the group consisting of dibenzylidene sorbitol, tribenzylidene sorbitol and derivatives thereof, and the resin component comprises a combination of polyvinyl butyral resin having an average degree of polymerization of less than 350 and polyvinyl butyral resin having an average degree of polymerization of 350 or more. | 2009-08-20 |
20090209679 | CORE-SHELL FLOW IMPROVER - A flow improver comprising a plurality of core-shell particles that can be formed by emulsion polymerization. The core of the core-shell particles can include a drag reducing polymer, while the shell of the particles can include repeat units of a hydrophobic compound and an amphiphilic compound. The flow improver can demonstrate increased pumping stability over conventionally prepared latex flow improvers. | 2009-08-20 |
20090209680 | Process for preparing a nanocomposite rigid material - The invention relates to a process for preparing a material consisting of a PVC matrix reinforced with clay comprising the following successive stages:
| 2009-08-20 |
20090209681 | UREA-FORMALDEHYDE RESIN REINFORCED GYPSUM COMPOSITES AND BUILDING MATERIALS MADE THEREFROM - A composite material containing substantially homogeneous matrix of a gypsum material and a urea-formaldehyde material where wet-used chopped strand fibers are filamentized within the substantially homogeneous matrix. | 2009-08-20 |
20090209682 | Use of an organic additve for producing porous concrete - In order to produce porous concrete, the use of an organic additive with water-reducing, dispersing and/or flowability-increasing properties is provided. This additive is at least one representative of the series of polycondensation products based on naphthalinsulfonic acids or alkylnaphthalinsulfonic acids, melamine-formaldehyde resins containing sulfonic acid groups, and copolymers based on unsaturated mono- or dicarboxylic acid derivatives and on oxyalkylene glycol-alkenyl ethers. This additive is preferably admixed to a non-foamed and, in particular, mixing water-free porous concrete base mix containing lime, a hydraulic binder, preferably cement and sand, whereby quantities between 0.01 and 10% by weight are considered as preferred quantities. By using the additive in the aforementioned manner, the method for producing porous concrete can be carried out using distinctly less energy and thus more cost-effectively without negatively influencing the typical properties of porous concrete products. | 2009-08-20 |
20090209683 | TWO-STEP MIXING PROCESS FOR PRODUCING AN ABSORBENT POLYMER - A process for producing an absorbent polymer including a first mixing event, in which a plurality of absorbent polymer particles ( | 2009-08-20 |
20090209684 | USE OF A METAL ORGANOSILICATE POLYMER AS DISPERSION-FORMING AGENT - The invention relates to the use of a metal organosilicate polymer as a dispersion-forming agent. The metal organosilicate polymer used in the invention has one of the following formulae I and II: | 2009-08-20 |
20090209685 | Adhesive Solution for Application to the Skin - This invention relates to an adhesive solution for removably attaching items to the skin comprising: (i) a solids content comprising a vinyl pyrrolidone copolymer, and either a plasticiser, and a separate wetting agent, or a compound that acts as both plasticiser and wetting agent (ii) water as a first solvent; and (iii) an alcohol as a second solvent wherein the amount of alcohol does not exceed 20 wt % of the whole solution, and the glass transition temperature (Tg) of the copolymer composition (i) is below 40° C. | 2009-08-20 |
20090209686 | Eraser - Provided is a plastic eraser excellent in safety and environmental pollution resistance and, not detracting from the erasability thereof, further excellent in bleeding resistance and eraser dust gatherability. The eraser comprises a base resin such as a vinyl chloride resin and, as incorporated therein as a plasticizer, a liquid acrylic polymer having a glass transition point (Tg) of not higher than 0° C. The eraser may comprise the liquid acrylic polymer alone or as combined with one or more other plasticizers. Containing the liquid acrylic polymer as a plasticizer, the eraser has excellent bleeding resistance and excellent dust gatherability which could hardly be balanced. | 2009-08-20 |
20090209687 | HYBRID CLAYS FOR OBTAINING NANOCOMPOSITES AND A PREPARATION PROCESS THEREFORE - Hybrid clays for obtaining nanocomposites useful in the automotive, aviation, construction and packaging industry, among others. The hybrid clay comprises clays intercalated with the itaconic acid (ITA) monomer or its derivative monooctadecyl itaconate (MODIT), and a process for the preparation of these hybrid clays and the process to obtain polyolefin/clay nanocomposites. | 2009-08-20 |
20090209688 | SILICON CONTAINING COMPOUND AS DRYING AGENT FOR POLYOLEFIN COMPOSITIONS - The present invention relates to the use of a silicon containing compound as drying agent of a polyolefln composition comprising a crosslinkable polyolefin with hydrolysable silane groups, wherein the silicon containing compound has a structure according to the formula (R | 2009-08-20 |
20090209689 | Corrosion and abrasion resistant coating - A corrosion and abrasion resistant coating composition with at least one alkoxy siloxane and preferably at least three alkoxy siloxanes, wherein the total amount of alkoxy siloxanes in the composition is greater than approximately 70 wt %, an anti-corrosion agent effective in acid and salt environments, a hydrolysable catalyst, an adhesion promoter, and a flow/leveling agent. | 2009-08-20 |
20090209690 | RUBBER WITH COMBINATION OF SILICA AND PARTIALLY DECARBOXYLATED ROSIN ACID AND TIRE WITH COMPONENT THEREOF - This invention relates to rubber compositions which contain a combination of silica reinforcement and plant-derived liquid partially decarboxylated rosin acid and to tires having components thereof, such as, for example, tire treads. Said liquid partially decarboxylated rosin acid acts both as a processing aid for the mixing of the rubber composition and as an aid to reinforcement of the rubber composition by interaction with the silica in situ within the rubber composition. | 2009-08-20 |
20090209691 | TRIAZINETHIOL AND ALKENYL-CONTAINING ORGANOPOLYSILOXANE, MAKING METHOD, AND PRIMER COMPOSITION COMPRISING SAME - An organopolysiloxane having triazinethiol and alkenyl radicals in a molecule and a primer composition comprising the same are provided. The primer composition assists in establishing a high bond strength between metal and silicone rubber by the mechanism that the triazinethiol moieties form strong chemical bonds with a difficult-to-bond metal such as gold, silver or copper, and the alkenyl moieties are involved in silicone rubber vulcanization. | 2009-08-20 |
20090209692 | DISPERSING AND/ OR GRINDING AID AGENT FOR DISPERSION AND AQUEOUS SUSPENSION OF MINERAL MATERIALS, DISPERSION AND SUSPENSION OBTAINED AND USE THEREOF - The invention relates to the use of at least one polymer containing at least one monomer selected from acrylic acid or methacrylic acid or mixtures thereof and at least one monomer which is the maleic anhydride as a dispersing and/or grinding aid agent in a fabrication process of an aqueous dispersion and/or suspension of mineral materials, wherein the molar ratio r (acrylic acid and/or methacrylic acid:(maleic anhydride) is strictly confined to the range between 2:1 and 0.1:1. | 2009-08-20 |
20090209693 | Silver Beta-Ketocarboxylate, Material Comprising the Same for Forming Silver Metal, and Use Thereof - It is an object to provide a novel material that can quickly form metal silver even at a low temperature of approximately 210° C. or less. This serves as a metal silver forming material that includes a silver β-ketocarboxylate. By heating this forming material, it is possible to form metal silver quickly even at a low temperature of approximately 210° C. or less. Examples of the silver β-ketocarboxylate include silver isobutyrylacetate, silver benzoylacetate, silver acetoacetate, silver propionylacetate, silver α-methylacetoacetate, and silver α-ethylacetoacetate. | 2009-08-20 |
20090209694 | Process for Nanocomposites Preparation, and Nanocomposites - The present invention relates the preparation process of nanocomposites polyolefins based on organophilic clay and polyolefins. More specifically, the present invention relates to a process to prepare nanocomposites, which provides more efficient exfoliation of organophilic clay particles in the polymeric matrix and, hence, a product with significantly improved mechanical, thermal and barrier properties, and good optical properties. | 2009-08-20 |
20090209695 | THERMOPLASTIC POLYCARBONATE/POLYESTER BLEND COMPOSITIONS WITH IMPROVED MECHANICAL PROPERTIES - Disclosed is a thermoplastic composition comprising a mixture of from 10 to 98 weight % of a polycarbonate polymer, from 2 to 90 weight % of a polyester polymer comprising structures derived from a diol compound having the structure (A) HO-Z-OH, wherein Z is a C | 2009-08-20 |
20090209696 | Thermoplastic Resin Composition and Plastic Article - Disclosed herein are a thermoplastic resin composition and a plastic article produced from the resin composition. The thermoplastic resin composition comprises a thermoplastic resin, glass fibers having a cross-sectional aspect ratio greater than or equal to about 1.5, and a branched graft copolymer comprising a polyolefin as a main chain. | 2009-08-20 |
20090209697 | Moulding Compositions Based on a Thermoplastic Polycarbonate - This invention relates to thermoplastic moulding compositions with improved flowability based on a thermoplastic polycarbonate and on a copolymer of at least one olefin with at least one methacrylic ester or acrylic ester of an aliphatic alcohol, where the MFI of the copolymer is no less than 100 g/10 min, to a process for preparation of these moulding compositions, and also to the use of these moulding compositions for production of mouldings for the electrical industry, electronics industry, telecommunications industry, motor vehicle industry, or computer industry, in sports, in medicine, in households, or in the entertainment industry. | 2009-08-20 |
20090209698 | PROCESS FOR THE PREPARATION OF AN ARTIFICIAL LATEX - A process for the preparation of an aqueous rubber emulsion (artificial latex), comprising the steps:
| 2009-08-20 |
20090209699 | Method of producing a rubber composition - The invention is directed to a method of manufacturing a rubber composition with improved processing properties and optimized abrasion characteristics. Three methods with differing number of processing steps for the manufacture of a rubber composition with improved processing properties and optimized abrasion characteristics are disclosed. | 2009-08-20 |
20090209700 | CERAMIC GREEN SHEET AND METHOD FOR PRODUCING THE SAME - The invention provides a ceramic green sheet having plasticity, punching property, and sinterability of satisfactory levels as well as a low percent (heat) shrinkage. In the production of a ceramic slurry serving as a raw material of the sheet, ingredients thereof are mixed under such conditions that the functional group ratio (polyol to isocyanate) is 1.5/11.5 to 11.5/11.5; the urethane resin formed from isocyanate and polyol has a repeating-unit-based molecular weight of 290 to 988; and the ratio by weight of the urethane resin to a ceramic powder falls within a range of 4.5 to 10 parts by weight of the urethane resin with respect to 100 parts by weight of the ceramic powder. As a result, a ceramic green sheet having, in well balance, all of the properties (i.e., plasticity, punching property, sinterability, and (heat) shrinkage) required for facilitating subsequent processes such as mechanical working and firing can be provided. | 2009-08-20 |
20090209701 | WATER-BASED LACQUERS COMPRISING HIGHLY FUNCTIONAL, HIGHLY BRANCHED OR HYPERBRANCHED POLYCARBONATES - The present invention relates to aqueous basecoat materials which comprise high-functionality, highly branched or hyperbranched polycarbonates based on dialkyl or diaryl carbonates or on phosgene, diphosgene or triphosgene and on aliphatic, aliphatic/aromatic or aromatic diols or polyols. | 2009-08-20 |
20090209702 | Slurry phase polymerisation process - A process comprising polymerising in a loop reactor of continuous tubular construction an olefin monomer optionally together with an olefin comonomer in the presence of a polymerisation catalyst in a diluent to produce a slurry comprising solid particulate olefin polymer and the diluent wherein the internal diameter of at least 50% of the total length of the reactor is at least 700 millimeters and the solids concentration in the reactor is at least 20 volume % is disclosed. | 2009-08-20 |